{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:10:52Z","timestamp":1788174652576,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalspathology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.anndiagpath.2016.12.001","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T17:19:12Z","timestamp":1481822352000},"page":"24-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR\u2013ABL1: A report of three cases from India"],"prefix":"10.1016","volume":"27","author":[{"given":"Sudha","family":"Sazawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Chikkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaljeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Chaubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravas","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0005","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1182\/blood-2009-02-204693","article-title":"Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance","volume":"114","author":"Verma","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2141.2004.05119.x","article-title":"Insertion of a genomic fragment of chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic myeloid leukaemia patient with micro-BCR-ABL (e19a2) transcript","volume":"126","author":"Ito","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0015","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2013 a Europe cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0020","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissue: Chronic neutrophilic leukaemia","first-page":"38","author":"Bain","year":"2008"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0025","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood.V76.9.1819.1819","article-title":"New type of Bcr\/Abl junction in Philadelphia chromosome\u2014positive chronic myelogenous leukemia","volume":"9","author":"Saglio","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0030","doi-asserted-by":"crossref","unstructured":"Arana-Trejo RM, Sanchez ER, Ignacio-Ibarra G et al. BCR\/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia. Clin. Lab. Haem. 2002; 24: 145\u201350.","DOI":"10.1046\/j.1365-2257.2002.00413.x"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0035","first-page":"247","article-title":"Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia","volume":"11","author":"Yaghmaie","year":"2008","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0040","first-page":"42","article-title":"Cytogenetic & molecular analyses in adult chronic myelogenous leukemia patients in North Indian","volume":"135","author":"Anand","year":"2012","journal-title":"J Med Res"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jcp.2005.029595","article-title":"e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukemia: a report of two cases","volume":"59","author":"Mondal","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","article-title":"The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity","volume":"189","author":"Li","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1200\/JCO.2013.51.1188","article-title":"Molecular response of E19A2 BCR-ABL1 chronic myeloid leukemia wih double Philadelphia chromosome to dasatinib","volume":"34","author":"Ikeda","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0060","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/sj.leu.2403454","article-title":"Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts","volume":"18","author":"Lee","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0065","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.leu.2403761","article-title":"Identification of e19a2 BCR-ABL fusions (mu-BCR breakpoints) at the DNA level by ligation-mediated PCR","volume":"19","author":"Boeckx","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0070","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jcp.2005.029595","article-title":"E19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases","volume":"59","author":"Mondal","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cancergencyto.2007.04.013","article-title":"A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript","volume":"176","author":"Li","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hon.822","article-title":"First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts","volume":"25","author":"Andrikovics","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.leukres.2007.03.001","article-title":"Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML","volume":"32","author":"Popo vici","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cancergencyto.2010.01.018","article-title":"Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation","volume":"199","author":"Oshikawa","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0095","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/j.leukres.2010.03.036","article-title":"A T315I mutation in e19a2 BCR\/ABL1 chronic myeloid leukemia responding to dasatinib","volume":"34","author":"Cea","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cancergencyto.2010.05.012","article-title":"Chronic myeloid leukemia with e19a2 atypical transcript: early imatinib resistance and complete response to dasatinib","volume":"201","author":"Martin","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/jcp.2010.078311","article-title":"E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib","volume":"63","author":"Bennour","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.12.001_bb0110","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.leukres.2011.05.010","article-title":"Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia","volume":"35","author":"Langabeer","year":"2012","journal-title":"Leuk Res"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:39:40Z","timestamp":1601253580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913416302581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":22,"alternative-id":["S1092913416302581"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.12.001","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR\u2013ABL1: A report of three cases from India","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}